Exosens company profile

EXENS · Euronext Paris · EUR

Compare Exosens
€50.00Change from previous close: −4.85%Absolute change: −€2.55

Close · November 20, 2026

Company profile

Exosens has 2,000 employees and is headquartered in Mérignac, France.

Its customers come from defense and surveillance, nuclear, industrial control, and life sciences and environment markets, and the company sells into France, the rest of Europe, North America, Asia and other international markets. Exosens designs, makes and sells electro-optical technologies organized in two segments: amplification, which covers image intensifier tubes, and detection and imaging, which spans cameras, sensors, imaging systems, and detectors for ions, electrons, photons and neutrons. Its products are marketed under the Exosens, Photonis, Xenics, Telops, El-Mul and Noxant brands, and the range also includes Geiger-Müller tubes, gamma and neutron detectors, and methane airborne detection solutions.

In the fiscal year ended 31 December 2025, revenue reached 468.2 million euros, up 22.1% from the previous year, and net income was 42.7 million euros. The company employs 2,000 people, and its headquarters are in Mérignac, France, where it was founded in 1937.

Company facts

Industry
Aerospace & Defense
Country
France
Headquarters
Building 5, 33700, Mérignac
Employees
2,000
Chief executive
Jerome Cerisier
Founded
1937
Fiscal year
January - December
Listing
EXENS · Euronext Paris
Currency
EUR
ISIN
FR001400Q9V2

Exosens and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ExosensEXENSFrance$2.78B2,00017.4%119.0
QinetiQ GroupQQ.United Kingdom$3.24B7,50012.5%—
LisiFIIFrance$3.3B9,4559.8%35.1
RENK GroupR3NKGermany$3.36B4,47810.7%44.9
Exail TechnologiesEXAFrance$2.35B2,3327.4%25.9
Theon InternationalTHEONNetherlands$2.33B76724.4%16.5

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Exosens with its competitors